NEXMAB
associated with 25 other trademarks
Pharmaceuticals, namely, monoclonal antibodies and fragments therefor for therapeutic purposes, namely the treatment and diagnosis of cancer, prolifer...

Words that describe this trademark:

monoclonal antibodies  diagnosis cancer  treatment diagnosis  pharmaceuticals  purposes  antibodies  fragments  therapeutic  cancer 

Serial Number:

77076778

Mark:

NEXMAB

Status:

Abandoned-No Statement of Use filed

Status Date:

06-15-2009

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals, namely, monoclonal antibodies and fragments therefor for therapeutic purposes, namely the treatment and diagnosis of cancer, proliferative cell diseases, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases Pharmaceutical and biological product development for others relating to monoclonal antibodies; consultation in the field of pharmaceutical and biological product development relating to monoclonal antibodies

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

08-21-2007

Mark Drawing Status:

Standart Character Mark

Abandon Date:

06-15-2009

Business Name:

COOLEY GODWARD KRONISH LLP

Correspondent Name:

Recent Trademark filings by this company